Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(100.0%)
1Total
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04784468Unknown

DNA Damage and Oxidative Stress in Hospitalized COVID-19 Patients

Role: collaborator

NCT04351724Phase 2Unknown

Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)

Role: collaborator

NCT03171909Unknown

Austrian Registry on the Outcome of Monochorionic Pregnancies

Role: collaborator

All 3 trials loaded